tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Geulah Livshits, 145 are a BUY (94.77%), 6 are a HOLD (3.92%), 2 are a SELL (1.31%).
Analyst Geulah Livshits, currently employed at CHARDAN CAPITAL, carries an average stock price target met ratio of 34.67% that have a potential upside of 90.95% achieved within 103 days.
Geulah Livshits’s has documented 281 price targets and ratings displayed on 30 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on RCKT, Rocket Pharmaceuticals at 20-Aug-2025.
Analyst best performing recommendations are on PASG (PASSAGE BIO).
The best stock recommendation documented was for PASG (PASSAGE BIO) at 6/24/2025. The price target of $6 was fulfilled within 20 days with a profit of $5.65 (1614.29%) receiving and performance score of 807.14.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$80
$12.26 (18.10%)
$80
16 days ago
(22-Sep-2025)
4/6 (66.67%)
$19.24 (31.67%)
100
Hold
$56
$-11.74 (-17.33%)
$42
2 months 3 days ago
(05-Aug-2025)
15/18 (83.33%)
$-0.34 (-0.60%)
131
Hold
$42
$-25.74 (-38.00%)
$38
2 months 4 days ago
(04-Aug-2025)
12/14 (85.71%)
$-13.59 (-24.45%)
164
Buy
$78
$10.26 (15.15%)
$86
2 months 17 days ago
(21-Jul-2025)
2/5 (40%)
$12.07 (18.31%)
32
Buy
$81
$13.26 (19.57%)
$81
3 months 1 days ago
(07-Jul-2025)
8/23 (34.78%)
$26.18 (47.76%)
214
Which stock is Geulah Livshits is most bullish on?
Which stock is Geulah Livshits is most reserved on?
What Year was the first public recommendation made by Geulah Livshits?
